Thymoquinone Glucuronide Conjugated Magnetic Nanoparticle for Bimodal Imaging and Treatment of Cancer as a Novel Theranostic Platform.

Autor: İnce İ; Ege University, Department of Nuclear Application, Institute of Nuclear Sciences, Izmir, Turkey., Müftüler ZB; Ege University, Department of Nuclear Application, Institute of Nuclear Sciences, Izmir, Turkey., Medine Eİ; Ege University, Department of Nuclear Application, Institute of Nuclear Sciences, Izmir, Turkey., Güldü ÖK; Ege University, Department of Nuclear Application, Institute of Nuclear Sciences, Izmir, Turkey., Takan G; Ege University, Department of Nuclear Application, Institute of Nuclear Sciences, Izmir, Turkey., Ergönül A; Ege University, Faculty of Medicine Department of Chest Surgery, Izmir, Turkey., Parlak Y; Celal Bayar University, Faculty of Medicine Department of Nuclear Medicine, Manisa, Turkey., Yıldırım Y; Ege University, Center for Drug R&D and Pharmacokinetic Applications (ARGEFAR), Izmir, Turkey., Çakar B; Ege University Faculty of Medicine, Division of Medical Oncology, Izmir, Turkey., Bilgin ES; Celal Bayar University, Faculty of Medicine Department of Nuclear Medicine, Manisa, Turkey., Aras Ö; Memorial Sloan Kettering Cancer Center, Department of Radiology, New York, United States., Göker E; Ege University Faculty of Medicine, Division of Medical Oncology, Izmir, Turkey., Ünak P; Ege University, Department of Nuclear Application, Institute of Nuclear Sciences, Izmir, Turkey.

Publikováno v: Current radiopharmaceuticals [Curr Radiopharm] 2021; Vol. 14 (1), pp. 23-36.